Cite
TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea.
MLA
Kim, Min Jhi, et al. “TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea.” Cancers, vol. 14, no. 19, Oct. 2022, p. 4928. EBSCOhost, https://doi.org/10.3390/cancers14194928.
APA
Kim, M. J., Kim, J. K., Kim, G. J., Kang, S.-W., Lee, J., Jeong, J. J., Chung, W. Y., Kim, D., & Nam, K.-H. (2022). TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea. Cancers, 14(19), 4928. https://doi.org/10.3390/cancers14194928
Chicago
Kim, Min Jhi, Jin Kyong Kim, Gi Jeong Kim, Sang-Wook Kang, Jandee Lee, Jong Ju Jeong, Woong Youn Chung, Daham Kim, and Kee-Hyun Nam. 2022. “TERT Promoter and BRAF V600E Mutations in Papillary Thyroid Cancer: A Single-Institution Experience in Korea.” Cancers 14 (19): 4928. doi:10.3390/cancers14194928.